Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,142) with videos related to
Page
of 115
Sort By:
Journal of Medical Screening
|
May 19, 2026
No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trial
Jason A Dominitz, Douglas J Robertson, Sophie Miller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 1, 2010
The catechol-O-methyl-transferase gene in tardive dyskinesia
Clement C Zai, Arun K Tiwari, Daniel J Müller, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
Bruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Gastrointestinal Endoscopy
|
May 9, 2022
Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort
Elizabeth A Kobe, Brian A Sullivan, Xuejun Qin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 17, 2009
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia
Clement C Zai, Arun K Tiwari, Vincenzo De Luca, et al.
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
Schizophrenia Research
|
March 15, 2006
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode
Diana O Perkins, Jacqueline L Johnson, Robert M Hamer, et al.
Journal of Psychiatric Research
|
September 11, 2013
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
Clement C Zai, Arun K Tiwari, Marina Mazzoco, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 7, 2012
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building
Eric A Sherer, Mark E Sale, Bruce G Pollock, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 29, 2010
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
Arun K Tiwari, Clement C Zai, Olga Likhodi, et al.
Page
of 115
Search research articles
Search
Showing results (1041-1050 of 1,142) with videos related to
Sort By:
Page
of 115
Journal of Medical Screening
|
May 19, 2026
No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trial
Jason A Dominitz, Douglas J Robertson, Sophie Miller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 1, 2010
The catechol-O-methyl-transferase gene in tardive dyskinesia
Clement C Zai, Arun K Tiwari, Daniel J Müller, et al.
Journal of Clinical Psychopharmacology
|
July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
Bruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Gastrointestinal Endoscopy
|
May 9, 2022
Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort
Elizabeth A Kobe, Brian A Sullivan, Xuejun Qin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 17, 2009
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia
Clement C Zai, Arun K Tiwari, Vincenzo De Luca, et al.
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
Schizophrenia Research
|
March 15, 2006
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode
Diana O Perkins, Jacqueline L Johnson, Robert M Hamer, et al.
Journal of Psychiatric Research
|
September 11, 2013
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
Clement C Zai, Arun K Tiwari, Marina Mazzoco, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 7, 2012
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building
Eric A Sherer, Mark E Sale, Bruce G Pollock, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 29, 2010
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
Arun K Tiwari, Clement C Zai, Olga Likhodi, et al.
Page
of 115